AI Article Synopsis

  • This case report focuses on a 10-year-old girl with Harlequin ichthyosis, a severe skin condition that causes excessive skin growth and fissures, making traditional treatments ineffective.
  • The introduction of nanobubble technology during a 100-hour medical trial at a dermatologist's office led to noticeable improvements in her skin condition after just one session.
  • The success of this treatment spurred the founding of the White Water Company to create portable nanobubblers, which not only help manage the skin symptoms but also improve biofilm remediation, offering a comprehensive solution for the patient.

Article Abstract

This case report details the management of a 10-year-old female pediatric patient with Harlequin ichthyosis (HI), a challenging skin disorder characterized by the production of 40 times the normal skin without trifats, leading to recurrent splits and fissures. Conventional treatments were ineffective until the introduction of nanobubbles. Encouraged by successful cases, the family engaged in a 100-hour medical trial conducted three days a week at the dermatologist's office, witnessing positive outcomes after the initial 20-minute session. The nanobubble's success inspired the creation of the White Water Company in 2016, developing the first portable nanobubbler. Nanobubble technology not only addressed excessive skin production but also played a crucial role in biofilm remediation, offering a solution to an additional challenge. The 100-hour medical trial demonstrated commitment to the patient's well-being. The nanobubble bath completed the scratch-itch cycle by shedding skin during the bath and moisturizing the skin from the inside out, providing a holistic solution to the challenges posed by HI.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11449885PMC
http://dx.doi.org/10.7759/cureus.68581DOI Listing

Publication Analysis

Top Keywords

harlequin ichthyosis
8
100-hour medical
8
medical trial
8
skin
5
ichthyosis nanobubble
4
nanobubble hydrotherapy
4
hydrotherapy breakthrough
4
breakthrough treatment
4
treatment case
4
case report
4

Similar Publications

Collodion baby is a rare congenital condition marked by a parchment-like membrane covering the body, often leading to complications such as bilateral ectropion. This condition poses risks of exposure keratopathy and other ocular issues. We present a case series of five infants with congenital bilateral ectropion associated with collodion babies, all born prematurely.

View Article and Find Full Text PDF

ABCA12 is crucial for skin barrier function and traditionally linked to severe congenital ichthyosis, such as harlequin ichthyosis. However, its genotype-phenotype relationship may be more nuanced. Using whole-exome sequencing and Sanger sequencing, we identified four cases of mild ichthyosis with biallelic ABCA12 pathogenic variants.

View Article and Find Full Text PDF
Article Synopsis
  • This case report focuses on a 10-year-old girl with Harlequin ichthyosis, a severe skin condition that causes excessive skin growth and fissures, making traditional treatments ineffective.
  • The introduction of nanobubble technology during a 100-hour medical trial at a dermatologist's office led to noticeable improvements in her skin condition after just one session.
  • The success of this treatment spurred the founding of the White Water Company to create portable nanobubblers, which not only help manage the skin symptoms but also improve biofilm remediation, offering a comprehensive solution for the patient.
View Article and Find Full Text PDF

A cellular disease model toward gene therapy of -dependent lamellar ichthyosis.

Mol Ther Methods Clin Dev

September 2024

Center for Regenerative Medicine "Stefano Ferrari", Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.

Lamellar ichthyosis (LI) is a chronic disease, mostly caused by mutations in the gene, marked by impaired skin barrier formation. No definitive therapies are available, and current treatments aim at symptomatic relief. LI mouse models often fail to faithfully replicate the clinical and histopathological features of human skin conditions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!